FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision
The disagreement between Moderna and the FDA has reached a resolution just eight days after the biotech received a Refusal-to-File letter in response to its application for mRNA-1010. Moderna will now seek approval of the vaccine based on age.
FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision Read More »
